Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.

Bruna R, Benedetti F, Boccomini C, Patti C, Barbui AM, Pulsoni A, Musso M, Liberati AM, Gini G, Castellino C, Rossini F, Ciceri F, Rota-Scalabrini D, Stelitano C, Di Raimondo F, Tucci A, Devizzi L, Zoli V, Zallio F, Narni F, Dondi A, Parvis G, Semenzato G, Lanza F, Perrone T, Angrilli F, Billio A, Gueli A, Mantoan B, Rambaldi A, Gianni AM, Corradini P, Passera R, Ladetto M, Tarella C.

Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.

2.

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO).

Candoni A, Rambaldi A, Fanin R, Velardi A, Arcese W, Ciceri F, Lazzarotto D, Lussana F, Olivieri J, Grillo G, Parma M, Bruno B, Sora F, Bernasconi P, Saccardi R, Foà R, Sessa M, Bresciani P, Giglio F, Picardi A, Busca A, Sica S, Perruccio K, Zucchetti E, Diral E, Iori AP, Colombo AA, Tringali S, Santarone S, Irrera G, Mancini S, Zallio F, Malagola M, Albano F, Carella AM, Olivieri A, Tecchio C, Dominietto A, Vacca A, Sorasio R, Orciuolo E, Risitano AM, Leotta S, Cortelezzi A, Mammoliti S, Oldani E, Bonifazi F; GITMO.

Biol Blood Marrow Transplant. 2019 Aug 7. pii: S1083-8791(19)30509-9. doi: 10.1016/j.bbmt.2019.07.037. [Epub ahead of print]

PMID:
31400502
3.

Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study.

Bonifazi F, Solano C, Wolschke C, Sessa M, Patriarca F, Zallio F, Nagler A, Selleri C, Risitano AM, Messina G, Bethge W, Herrera P, Sureda A, Carella AM, Cimminiello M, Guidi S, Finke J, Sorasio R, Ferra C, Sierra J, Russo D, Benedetti E, Milone G, Benedetti F, Heinzelmann M, Pastore D, Jurado M, Terruzzi E, Narni F, Völp A, Ayuk F, Ruutu T, Kröger N.

Lancet Haematol. 2019 Feb;6(2):e89-e99. doi: 10.1016/S2352-3026(18)30214-X. Erratum in: Lancet Haematol. 2019 Mar;6(3):e121.

PMID:
30709437
4.

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.

Olivieri J, Attolico I, Nuccorini R, Pascale SP, Chiarucci M, Poiani M, Corradini P, Farina L, Gaidano G, Nassi L, Sica S, Piccirillo N, Pioltelli PE, Martino M, Moscato T, Pini M, Zallio F, Ciceri F, Marktel S, Mengarelli A, Musto P, Capria S, Merli F, Codeluppi K, Mele G, Lanza F, Specchia G, Pastore D, Milone G, Saraceni F, Di Nardo E, Perseghin P, Olivieri A.

Bone Marrow Transplant. 2018 Apr;53(4):461-473. doi: 10.1038/s41409-017-0051-y. Epub 2018 Jan 12.

PMID:
29330395
5.

Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma.

Giaccone L, Evangelista A, Patriarca F, Sorasio R, Pini M, Carnevale-Schianca F, Festuccia M, Brunello L, Zallio F, Maffini E, Omedé P, Bringhen S, Mordini N, Fanin R, Ciccone G, Boccadoro M, Bruno B.

Biol Blood Marrow Transplant. 2018 Jan;24(1):189-193. doi: 10.1016/j.bbmt.2017.09.017. Epub 2017 Oct 4.

6.

Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma.

Giaccone L, Festuccia M, Zallio F, Sorasio R, Brunello L, Maffini E, Dellacasa C, Passera R, Iovino G, Aydin S, Boccadoro M, Vitolo U, Mordini N, Pini M, Busca A, Bruno B.

Bone Marrow Transplant. 2017 Aug;52(8):1208-1211. doi: 10.1038/bmt.2017.99. Epub 2017 Jun 5. No abstract available.

PMID:
28581461
7.

Infections and Follicular Lymphoma: is there a Link?

Zallio F, Limberti G, Ladetto M.

Mediterr J Hematol Infect Dis. 2017 May 1;9(1):e2017035. doi: 10.4084/MJHID.2017.035. eCollection 2017. Review.

8.

The Start-Up of the first Hematopoietic Stem Cell Transplantation Center in the Iraqi Kurdistan: a Capacity-Building Cooperative Project by the Hiwa Cancer Hospital, Sulaymaniyah, and the Italian Agency for Development Cooperation: an Innovative Approach.

Majolino I, Othman D, Rovelli A, Hassan D, Rasool L, Vacca M, Abdalrahman N, Abdullah C, Ahmed Z, Ali D, Ali K, Broggi C, Calabretta C, Canesi M, Ciabatti G, Del Fante C, De Sapio E, Dore G, Frigato A, Gabriel M, Ipsevich F, Kareem H, Karim D, Leone R, Mahmood T, Manna A, Massei MS, Mastria A, Mohammed D, Mohammed R, Najmaddin K, Noori D, Ostuni A, Palmas A, Possenti M, Qadir A, Real G, Shrif R, Valdatta C, Vasta S, Verna M, Vittori M, Yousif A, Zallio F, Calisti A, Quattrocchi S, Girmenia C.

Mediterr J Hematol Infect Dis. 2017 Apr 15;9(1):e2017031. doi: 10.4084/MJHID.2017.031. eCollection 2017.

9.

A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease.

Zallio F, Mazzucco L, Monaco F, Astori MR, Passera R, Drago G, Tamiazzo S, Rapetti M, Dolcino D, Guaschino R, Pini M, Ladetto M.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1664-1670. doi: 10.1016/j.bbmt.2016.05.023. Epub 2016 Jun 4.

10.

Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL).

Zallio F, Tamiazzo S, Monagheddu C, Merli F, Ilariucci F, Stelitano C, Liberati AM, Mannina D, Vitolo U, Angelucci E, Rota Scalabrini D, Vallisa D, Bellei M, Bari A, Ciccone G, Salvi F, Levis A.

Br J Haematol. 2016 Mar;172(6):879-88. doi: 10.1111/bjh.13904. Epub 2016 Jan 13.

PMID:
26763986
11.

The use of ATG abrogates the antileukemic effect of cytomegalovirus reactivation in patients with acute myeloid leukemia receiving grafts from unrelated donors.

Busca A, Passera R, Pini M, Zallio F, Dellacasa C, Audisio E, Giaccone L, Maffini E, Costa C, Cavallo R, Bruno B.

Am J Hematol. 2015 Jun;90(6):E117-21. doi: 10.1002/ajh.23998. Epub 2015 Apr 1.

12.

Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphoma.

Catania G, Zallio F, Monaco F, Corsetti MT, Trincheri N, Bonello L, Mele L, Dallavalle F, Salvi F, Pini M.

Leuk Res Rep. 2014 Oct 28;3(2):90-3. doi: 10.1016/j.lrr.2014.09.001. eCollection 2014.

13.

Comparison of maxillary molar distalization with an implant-supported distal jet and a traditional tooth-supported distal jet appliance.

Cozzani M, Pasini M, Zallio F, Ritucci R, Mutinelli S, Mazzotta L, Giuca MR, Piras V.

Int J Dent. 2014;2014:937059. doi: 10.1155/2014/937059. Epub 2014 Jun 11.

14.

Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation.

Mariotti J, Maura F, Spina F, Roncari L, Dodero A, Farina L, Montefusco V, Carniti C, Sarina B, Patriarca F, Rambaldi A, Onida F, Olivieri A, Zallio F, Corradini P.

Biol Blood Marrow Transplant. 2014 Jun;20(6):885-90. doi: 10.1016/j.bbmt.2014.02.015. Epub 2014 Feb 28.

15.

Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.

Zallio F, Primon V, Tamiazzo S, Pini M, Baraldi A, Corsetti MT, Gotta F, Bertassello C, Salvi F, Rocchetti A, Levis A.

Clin Transplant. 2013 Jul-Aug;27(4):E491-7. doi: 10.1111/ctr.12172. Epub 2013 Jun 19.

PMID:
23781897
16.

An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients.

Cortelezzi A, Gritti G, Laurenti L, Cuneo A, Ciolli S, Di Renzo N, Musto P, Mauro FR, Cascavilla N, Falchi L, Zallio F, Callea V, Maura F, Martinelli S, Piciocchi A, Reda G, Foà R; GIMEMA Chronic Lymphoproliferative Disorders Working Party.

Br J Haematol. 2012 Feb;156(4):481-9. doi: 10.1111/j.1365-2141.2011.08965.x. Epub 2011 Dec 9.

17.

Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment.

Casabianca A, Marchetti M, Zallio F, Feyles E, Concialdi E, Ferroglio E, Biglino A.

Infection. 2011 Aug;39(4):375-8. doi: 10.1007/s15010-011-0109-5. Epub 2011 May 3.

PMID:
21538038
18.

Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C.

Corsetti MT, Salvi F, Perticone S, Baraldi A, De Paoli L, Gatto S, Pietrasanta D, Pini M, Primon V, Zallio F, Tonso A, Alvaro MG, Ciravegna G, Levis A.

Leuk Res. 2011 Aug;35(8):991-7. doi: 10.1016/j.leukres.2011.02.021. Epub 2011 Apr 6.

PMID:
21474179
19.

Efficiency of the distal screw in the distal movement of maxillary molars.

Cozzani M, Zallio F, Lombardo L, Gracco A.

World J Orthod. 2010 Winter;11(4):341-5.

PMID:
21490999
20.

Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial.

Ferreri AJ, Ponzoni M, Guidoboni M, Resti AG, Politi LS, Cortelazzo S, Demeter J, Zallio F, Palmas A, Muti G, Dognini GP, Pasini E, Lettini AA, Sacchetti F, De Conciliis C, Doglioni C, Dolcetti R.

J Natl Cancer Inst. 2006 Oct 4;98(19):1375-82.

PMID:
17018784
21.

Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation.

Corradini P, Tarella C, Zallio F, Dodero A, Zanni M, Valagussa P, Gianni AM, Rambaldi A, Barbui T, Cortelazzo S.

Leukemia. 2006 Sep;20(9):1533-8. Epub 2006 Jul 27.

PMID:
16871285
22.

Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies.

Corradini P, Zallio F, Mariotti J, Farina L, Bregni M, Valagussa P, Ciceri F, Bacigalupo A, Dodero A, Lucesole M, Patriarca F, Rambaldi A, Scimè R, Locasciulli A, Bandini G, Gianni AM, Tarella C, Olivieri A.

J Clin Oncol. 2005 Sep 20;23(27):6690-8.

PMID:
16170177
23.

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

Corradini P, Dodero A, Zallio F, Caracciolo D, Casini M, Bregni M, Narni F, Patriarca F, Boccadoro M, Benedetti F, Rambaldi A, Gianni AM, Tarella C.

J Clin Oncol. 2004 Jun 1;22(11):2172-6.

PMID:
15169805
24.

Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes.

Corradini P, Ladetto M, Zallio F, Astolfi M, Rizzo E, Sametti S, Cuttica A, Rosato R, Farina L, Boccadoro M, Benedetti F, Pileri A, Tarella C.

J Clin Oncol. 2004 Apr 15;22(8):1460-8.

PMID:
15084619
25.

Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.

Cuttica A, Zallio F, Ladetto M, Di Nicola M, Caracciolo D, Magni M, Marinone C, Dell'Aquila M, Rosace M, Pileri A, Boccadoro M, Gianni AM, Tarella C.

Cancer. 2003 Sep 1;98(5):983-92.

26.

High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.

Tarella C, Di Nicola M, Caracciolo D, Zallio F, Cuttica A, Omedè P, Bondesan P, Magni M, Matteucci P, Gallamini A, Pileri A, Gianni AM.

Bone Marrow Transplant. 2002 Dec;30(11):725-32.

27.

Feasibility of peripheral blood progenitor cell mobilization and harvest to support chemotherapy intensification in elderly patients with poor prognosis: non-Hodgkin's lymphoma.

Zallio F, Cuttica A, Caracciolo D, Gavarotti P, Bergui L, Giaretta F, Bondesan P, Tassi V, Gallo E, Pileri A, Tarella C.

Ann Hematol. 2002 Aug;81(8):448-53. Epub 2002 Aug 2.

PMID:
12224002
28.

High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments.

Tarella C, Cuttica A, Caracciolo D, Zallio F, Ricca I, Bergui L, Gavarotti P, Marinone C, Pagano M, Rossi G, de Crescenzo A, Salomone A, Ladetto M, Boccadoro M, Pileri A.

Ann Hematol. 2001;80 Suppl 3:B123-6. Review. No abstract available.

PMID:
11757693
29.

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.

Corradini P, Tarella C, Olivieri A, Gianni AM, Voena C, Zallio F, Ladetto M, Falda M, Lucesole M, Dodero A, Ciceri F, Benedetti F, Rambaldi A, Sajeva MR, Tresoldi M, Pileri A, Bordignon C, Bregni M.

Blood. 2002 Jan 1;99(1):75-82.

PMID:
11756155
30.

Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma.

Ladetto M, Zallio F, Vallet S, Ricca I, Cuttica A, Caracciolo D, Corradini P, Astolfi M, Sametti S, Volpato F, Bondesan P, Vitolo U, Boccadoro M, Pileri A, Gianni AM, Tarella C.

Leukemia. 2001 Dec;15(12):1941-9.

31.

Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas.

Guglielmi C, Martelli M, Federico M, Zinzani PL, Vitolo U, Bellesi G, Santini G, Tarella C, Zallio F, Pregno P, Di Renzo N, Resegotti L; Italian Intergroup for Lymphomas.

Haematologica. 2001 Sep;86(9):941-50.

32.

High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity.

Tarella C, Zallio F, Caracciolo D, Cuttica A, Corradini P, Gavarotti P, Ladetto M, Podio V, Sargiotto A, Rossi G, Gianni AM, Pileri A.

Leukemia. 2001 Feb;15(2):256-63.

33.

Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft.

Tarella C, Caracciolo D, Gavarotti P, Argentino C, Zallio F, Corradini P, Novero D, Magnani C, Pileri A.

Bone Marrow Transplant. 2000 Dec;26(11):1185-91.

34.

Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft.

Tarella C, Caracciolo D, Corradini P, Zallio F, Ladetto M, Cuttica A, Rossi G, Novero D, Gavarotti P, Pileri A.

Leukemia. 2000 Apr;14(4):740-7.

35.

Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patients.

Tarella C, Zallio F, Caracciolo D, Cherasco C, Bondesan P, Gavarotti P, Corradini P, Tassi V, Pileri A.

Stem Cells. 1999;17(1):55-61.

36.

[Depth of the curve of Spee in relation to FMA, FH, ANB and dental class].

Ghezzi F, Drago E, De Thomatis P, Zallio F.

Mondo Ortod. 1991 Jan-Feb;16(1):73-6. Italian.

PMID:
2072946
37.

[Dental anomalies due to fusion and gemination].

Ghezzi F, Vitali L, Zallio F.

Minerva Stomatol. 1987 Apr;36(4):241-7. Italian. No abstract available.

PMID:
3474501
38.

[Dental reimplantation. The clinico-biological considerations and practical guides].

Ghezzi F, Mazzarello GP, Zallio F.

Minerva Stomatol. 1986 Sep;35(9):879-85. Italian. No abstract available.

PMID:
3466014
39.

[Epidemiological study of the incidence of caries and malocclusion in the deciduous dentition of the children in USL 16 nursery schools (Genoa-Levante)].

Ghezzi F, Zallio F, Mazzarello GP, Tampelloni C.

Minerva Stomatol. 1986 Mar;35(3):107-12. Review. Italian. No abstract available.

PMID:
3515153
40.

[The Jarabak method of growth prediction. Diagnostic considerations and therapeutic implications].

Ghezzi F, Calcagno E, Zallio F.

Parodontol Stomatol (Nuova). 1986 Jan-Apr;25(1):9-16. Italian. No abstract available.

PMID:
3097614
41.

[Anchorage preparation in edgewise technic according to the Tweed school].

Ghezzi F, Servetto R, Zallio F.

Parodontol Stomatol (Nuova). 1986 Jan-Apr;25(1):83-96. Italian. No abstract available.

PMID:
3097613
42.

[The use of a simple functional regulator in interceptive orthodontic therapy].

Ghezzi F, Zallio F, Mazzarello GP.

Parodontol Stomatol (Nuova). 1986 Jan-Apr;25(1):71-82. Italian. No abstract available.

PMID:
3097612
43.

[The curve of Spee in Tweed's occlusion].

Zallio F, Ghezzi F, Vitali L.

Parodontol Stomatol (Nuova). 1986 Jan-Apr;25(1):67-70. Italian. No abstract available.

PMID:
3097611
44.

[Reconstruction with a dentin adhesive using the original fracture fragment].

Zallio F, Ghezzi F.

Parodontol Stomatol (Nuova). 1986 Jan-Apr;25(1):23-5. Italian. No abstract available.

PMID:
3097605
45.

[Occlusion according to the Tweed school].

Ghazzi F, Zallio F, Mazzarello GP.

Parodontol Stomatol (Nuova). 1986 Jan-Apr;25(1):17-21. Italian. No abstract available.

PMID:
3097604
46.

[Clinical use of fosfomycin in bacterial infections of the oral cavity in childhood].

Ghezzi F, Zallio F.

Minerva Stomatol. 1985 Jul-Aug;34(4):703-6. Italian. No abstract available.

PMID:
3862951
47.

[Orthodontic therapy for contraction of the upper jaw: rapid expansion of the palate].

Ghezzi F, Zallio F, Calcagno E.

Parodontol Stomatol (Nuova). 1985 May-Aug;24(2):131-44. Italian. No abstract available.

PMID:
3939004
48.

[Dens invaginatus--clinical cases].

Ghezzi F, Zallio F, Mazzarello G.

Parodontol Stomatol (Nuova). 1985 May-Aug;24(2):121-9. Italian. No abstract available.

PMID:
3939003
49.

[Reflex control of mastication: current views].

Calcagno E, Zallio F, Mazzarello GP, Ghezzi F.

Parodontol Stomatol (Nuova). 1985 Jan-Apr;24(1):79-82. Italian. No abstract available.

PMID:
3938001
50.

[Periodontal receptors].

Calcagno E, Ghezzi F, Mazzarello GP, Zallio F.

Parodontol Stomatol (Nuova). 1985 Jan-Apr;24(1):75-8. Italian. No abstract available.

PMID:
3938000

Supplemental Content

Loading ...
Support Center